Literature DB >> 12235491

Anderson-Fabry disease with cerebrovascular complications in two Italian families.

W Borsini1, G Giuliacci, F Torricelli, E Pelo, F Martinelli, M R Scordo.   

Abstract

We describe four patients with cerebrovascular complications from two unrelated Italian families with Anderson-Fabry disease. Clinical examination, neuroimaging (MRI), biochemical and genetic analyses were carried out in all the patients. Alpha-galactosidase A activity was detected by fluorimetric assay and genetic analysis was performed by DNA sequencing. Family 1. A male patient presented recurrent strokes when he was 34 years old, albuminuria and subsequently progressive renal failure to renal transplantation. Family 2. A male patient, aged 32 years, had diplopia for a few days and then recurrent strokes with left spastic hemiparesis and internuclear ophthalmoplegia. A female patient, aged 48 years, presented L-dopa-responsive parkinsonism, and her sister had stroke when she was 55 years old. MRI was abnormal in all the patients and showed lacunar infarctions in the periventricular white matter, basal ganglia and pons. Lesions were detected by MRI even before stroke in a female patients. In patients with Anderson-Fabry disease, stroke is a frequent complication, and may be the first threatening clinical manifestation. In young people with undefined stroke, even without signs of renal involvement, it is important to consider the diagnosis of Anderson-Fabry disease and so to perform clinical examination and biochemical analyses. The pre-clinical stage of cerebrovascular involvement may be evaluable by MRI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235491     DOI: 10.1007/s100720200025

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

1.  [Fabry disease: new clinical research--current therapeutic perspectives].

Authors:  Michael Beck
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

Review 2.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

3.  Diffuse structural and metabolic brain changes in Fabry disease.

Authors:  Silvia Marino; Walter Borsini; Susanna Buchner; Marzia Mortilla; Maria L Stromillo; Marco Battaglini; Antonio Giorgio; Placido Bramanti; Antonio Federico; Nicola De Stefano
Journal:  J Neurol       Date:  2006-03-20       Impact factor: 4.849

4.  Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.

Authors:  G Altarescu; G Chicco; C Whybra; S Delgado-Sanchez; N Sharon; M Beck; D Elstein
Journal:  J Inherit Metab Dis       Date:  2008-01-05       Impact factor: 4.982

5.  The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.

Authors:  Michael P Nelson; Michel Boutin; Tonia E Tse; Hailin Lu; Emily D Haley; Xiaosen Ouyang; Jianhua Zhang; Christiane Auray-Blais; John J Shacka
Journal:  Neurobiol Dis       Date:  2017-12-02       Impact factor: 5.996

6.  Alpha galactosidase A activity in Parkinson's disease.

Authors:  R N Alcalay; P Wolf; O A Levy; U J Kang; C Waters; S Fahn; B Ford; S H Kuo; N Vanegas; H Shah; C Liong; S Narayan; M W Pauciulo; W C Nichols; Z Gan-Or; G A Rouleau; W K Chung; P Oliva; J Keutzer; K Marder; X K Zhang
Journal:  Neurobiol Dis       Date:  2018-02-02       Impact factor: 5.996

7.  Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.

Authors:  Mylene Huebecker; Elizabeth B Moloney; Aarnoud C van der Spoel; David A Priestman; Ole Isacson; Penelope J Hallett; Frances M Platt
Journal:  Mol Neurodegener       Date:  2019-11-08       Impact factor: 14.195

8.  Clinical prodromes of neurodegeneration in Anderson-Fabry disease.

Authors:  Matthias Löhle; Derralynn Hughes; Alan Milligan; Linda Richfield; Heinz Reichmann; Atul Mehta; Anthony H V Schapira
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

9.  Prevalence of Fabry Disease among Patients with Parkinson's Disease.

Authors:  Alexandra Lackova; Christian Beetz; Sebastian Oppermann; Peter Bauer; Petra Pavelekova; Tatiana Lorincova; Miriam Ostrozovicova; Kristina Kulcsarova; Jana Cobejova; Martin Cobej; Petra Levicka; Simona Liesenerova; Daniela Sendekova; Viktoria Sukovska; Zuzana Gdovinova; Vladimir Han; Mie Rizig; Henry Houlden; Matej Skorvanek
Journal:  Parkinsons Dis       Date:  2022-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.